Extra Strength Headache Relief (Acetaminophen 250 mg/aspirin 250 mg/Caffeine 65 mg) tablets, 2-ta...
FDA Drug Recall #D-1513-2020 — Class III — August 3, 2020
Recall Summary
| Recall Number | D-1513-2020 |
| Classification | Class III — Low risk |
| Date Initiated | August 3, 2020 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Ultra Seal Corporation |
| Location | New Paltz, NY |
| Product Type | Drugs |
| Quantity | 701,735 packets |
Product Description
Extra Strength Headache Relief (Acetaminophen 250 mg/aspirin 250 mg/Caffeine 65 mg) tablets, 2-tablet packets, Manufactured for: Convenience Valet Glendale Heights, IL 60139,
Reason for Recall
Failed Stability Specifications: Out-of-Specification (OOS) results for the Aspirin related compound Salicylic Acid was observed.
Distribution Pattern
Product was shipped to two distributors in IL and TX who may have further repackaged and distributed the product.
Lot / Code Information
Lot #: K-8909, AK8909, Exp. Date 12/2020; AK9507, Exp. Date 03/2021; AK9072, Exp. Date 04/2021; AK9102, AK9601, AK9679, Exp. Date 05/2021; AK9145, K9145, Exp. Date 06/2021; AK9743, AK9830, Exp. Date 07/2021; AK9276, Exp. Date 09/2021; AK9391, A9392, Exp. Date 12/2021; AK9505, Exp. Date 02/2022; AK9508, AK9509 Exp. Date 04/2022
Other Recalls from Ultra Seal Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0497-2022 | Class II | Pain & Sinus Reliever Pain Reliever/Nasal Decon... | Jan 24, 2022 |
| D-0482-2022 | Class II | Backache & Muscle Relief (acetaminophen 250 mg,... | Jan 24, 2022 |
| D-0506-2022 | Class II | MidNite Natural sleep aid Chewable Tablets Cher... | Jan 24, 2022 |
| D-0481-2022 | Class II | Multi-Symptom Cramp Relief (acetaminophen 325mg... | Jan 24, 2022 |
| D-0487-2022 | Class II | COLD TERMINATOR decongestant/cold relief (aceta... | Jan 24, 2022 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.